
Find Reports
Select Report Type
Reimbursement Review
Displaying 1226 - 1250 of 1404
Please scroll or swipe to the right to view the full content.
Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
---|---|---|---|---|---|---|---|---|---|
quizartinibOpens in new tab | Vanflyta | quizartinib | acute myeloid leukemia (AML) | Active | PC0359-000 | ||||
Endometrial CancerOpens in new tab | Endometrial Cancer | Complete | PH0045-000 | ||||||
NSCLC without actionable oncog...Opens in new tab | NSCLC without actionable oncogenic alteration | Complete | PH0046-000 | ||||||
olopatadine hydrochloride and ...Opens in new tab | Ryaltris | olopatadine hydrochloride and mometasone | Seasonal allergic rhinitis | Active | SR0848-000 | ||||
dabrafenib trametinibOpens in new tab | Tafinlar-Mekinist | dabrafenib trametinib | Advanced or metastatic anaplastic thyroid cancer with BRAF V600E mutation | Cancelled | PC0337-000 | ||||
Unresectable Hepatocellular Ca...Opens in new tab | Unresectable Hepatocellular Carcinoma | Complete | PH0036-000 | ||||||
CADTH Pharmaceutical Reviews U...Opens in new tab | |||||||||
Renal cell carcinomaOpens in new tab | Renal cell carcinoma | Complete | PH0037-000 | ||||||
pegcetacoplanOpens in new tab | TBC | pegcetacoplan | Geographic atrophy secondary to age-related macular degeneration | Active | SR0810-000 | ||||
Triple Negative Breast CancerOpens in new tab | Triple Negative Breast Cancer | Complete | PH0024-000 | ||||||
CADTH Pharmaceutical Reviews U...Opens in new tab | |||||||||
Biologics in Plaque PsoriasisOpens in new tab | Complete | TS0001-000 | |||||||
Non-Small Cell Lung Cancer wit...Opens in new tab | Non-Small Cell Lung Cancer without actionable oncogenic alterations | Complete | PH0029-000 | ||||||
clascoteroneOpens in new tab | Winlevi | clascoterone | Acne vulgaris | Withdrawn | SR0786-000 | ||||
Adult B-Cell Precursor Acute L...Opens in new tab | Adult B-Cell Precursor Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative and Positive | Complete | PH0030-000 | ||||||
CADTH Pharmaceutical Reviews U...Opens in new tab | |||||||||
ibrutinibOpens in new tab | Imbruvica | ibrutinib | Leukemia | Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission. | Not filed | NS0004-000 | |||
durvalumabOpens in new tab | Imfinzi | durvalumab | resectable non-small cell lung cancer (NSCLC) | Suspended | PC0372-000 | ||||
Pharmaceutical Reviews Update ...Opens in new tab | |||||||||
Multiple MyelomaOpens in new tab | Multiple Myeloma | Complete | PH0047-000 | ||||||
Large B cell lymphomaOpens in new tab | Large B cell lymphoma | Complete | PH0048-000 | ||||||
Prostate CancerOpens in new tab | Prostate Cancer | Active | PH0050-000 | ||||||
Cutaneous MelanomaOpens in new tab | Cutaneous Melanoma | Complete | PH0049-000 | ||||||
garadacimabOpens in new tab | TBC | garadacimab | Hereditary angioedema (HAE) | Active | SR0860-000 | ||||
Advanced or metastatic gastric...Opens in new tab | Gastric Cancer | Complete | PH0051-000 |
Health Technology Review
Displaying 576 - 592 of 592
Horizon Scan
Displaying 101 - 111 of 111
Projects in Progress
Displaying 26 - 37 of 37
View All Reports
Displaying 1226 - 1250 of 2107
Please scroll or swipe to the right to view the full content.